VANDERBILT UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vumc.org
Respiratory Strength Training in Heart Transplant Recipients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT06190171
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Feasibility of Objective Measures and Outpatient Washout in Disease Modifying Trials for Parkinson's Disease
Recruiting
- Conditions
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT06192823
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Building Lipedema Research Resources
Recruiting
- Conditions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06180850
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effect of Ketamine and Etomidate During RSI on Long Term Outcomes
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-22
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 1756
- Registration Number
- NCT06179485
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-12-19
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT06176118
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT06162715
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
- First Posted Date
- 2023-11-09
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT06124196
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Enhancing Parent/Caregiver Engagement in the Pediatric Intensive Care Unit (PICU): A PICU Journal
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-05-21
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT06117345
- Locations
- 🇺🇸
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 63
- Registration Number
- NCT06113003
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Recruiting
- Conditions
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT06093100
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath